Trials / Completed
CompletedNCT03258190
Lime Powder Regimen (LPR) for Prevention of Renal Stone Recurrence
Lime Powder Regimen Supplement Alleviates Urinary Metabolic Abnormalities to Prevent Urolithiasis Recurrence.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 137 (actual)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Lime powder regimen (LPR) is a lime-derived composition enriches with citrate/citric acid and potassium. LPR was invented to treat the renal stone patients with high risk of stone recurrence after stone removal. LPR should have equal or higher efficacy and lower adverse effect than current standard medicine.
Detailed description
Lime powder regimen (LPR) is a mixture of lime-derive component with adjuvants containing high concentration of citrate, and moderate amount of potassium, magnesium and antioxidants. LPR was tested and verified to be very less toxic in cell culture and animal models. The clinical trial phase II showed that LPR reduced urinary metabolic abnormalities that enhance stone formation, such as hypocitraturia, hypokaliuria and acidified urine. Adverse effect of LPR was very low.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lime Powder Regimen | LPR and placebo were randomly given to subjects for 6 months |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2018-06-01
- Completion
- 2018-06-30
- First posted
- 2017-08-23
- Last updated
- 2019-02-01
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT03258190. Inclusion in this directory is not an endorsement.